Literature DB >> 26450781

How to use D-dimer in acute cardiovascular care.

Evangelos Giannitsis1, Johannes Mair2, Christina Christersson3, Agneta Siegbahn4, Kurt Huber5, Allan S Jaffe6, W Frank Peacock7, Mario Plebani8, Kristian Thygesen9, Martin Möckel10, Christian Mueller11, Bertil Lindahl12.   

Abstract

D-dimer testing is important to aid in the exclusion of venous thromboembolic events (VTEs), including deep venous thrombosis and pulmonary embolism, and it may be used to evaluate suspected aortic dissection. D-dimer is produced upon activation of the coagulation system with the generation and subsequent degradation of cross-linked fibrin by plasmin. Many different assays for D-dimer testing are currently used in routine care. However, these tests are neither standardized nor harmonized. Consequently, only clinically validated assays and assay specific decision limits should be used for routine testing. For the exclusion of pulmonary embolism/deep vein thrombosis, age-adjusted cut-offs are recommend. Clinicians must be aware of the validated use of their hospital's D-dimer assay to avoid inappropriate use of this biomarker in routine care.

Entities:  

Keywords:  D-dimer; acute cardiovascular care; pulmonary embolism; thrombosis

Mesh:

Substances:

Year:  2016        PMID: 26450781     DOI: 10.1177/2048872615610870

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  11 in total

Review 1.  Biomarker in cardiology : DGK welcomes ESC Munich 2018.

Authors:  H A Katus; E Giannitsis
Journal:  Clin Res Cardiol       Date:  2018-06-28       Impact factor: 5.460

2.  The relation between international normalized ratio and mortality in acute pulmonary embolism: A retrospective study.

Authors:  Tuncay Kırış; Selcuk Yazıcı; Gündüz Durmuş; Yiğit Çanga; Mustafa Karaca; Cem Nazlı; Abdullah Dogan
Journal:  J Clin Lab Anal       Date:  2017-02-18       Impact factor: 2.352

Review 3.  [Importance of biomarkers in pulmonary embolism].

Authors:  S Kupp; J Pöss
Journal:  Internist (Berl)       Date:  2019-06       Impact factor: 0.743

Review 4.  [Essential cardiac biomarkers in the differential diagnosis of acute chest pain : An update].

Authors:  M Vafaie; E Giannitsis; H A Katus
Journal:  Herz       Date:  2018-08       Impact factor: 1.443

5.  A pilot observational study on magnesium and calcium imbalance in elderly patients with acute aortic dissection.

Authors:  E Vianello; E Dozio; A Barassi; G Sammarco; L Tacchini; M M Marrocco-Trischitta; S Trimarchi; M M Corsi Romanelli
Journal:  Immun Ageing       Date:  2017-01-05       Impact factor: 6.400

6.  Characteristics and Treatment Outcomes of Acute Type A Aortic Dissection With Elevated D-Dimer Concentration.

Authors:  Ryo Itagaki; Naoyuki Kimura; Makiko Mieno; Daijiro Hori; Satoshi Itoh; Kei Akiyoshi; Koichi Yuri; Keisuke Tanno; Koji Kawahito; Atsushi Yamaguchi
Journal:  J Am Heart Assoc       Date:  2018-07-09       Impact factor: 5.501

7.  D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis.

Authors:  Hui Long; Lan Nie; Xiaochen Xiang; Huan Li; Xiaoli Zhang; Xiaozhi Fu; Hongwei Ren; Wanxin Liu; Qiang Wang; Qingming Wu
Journal:  Biomed Res Int       Date:  2020-06-16       Impact factor: 3.411

8.  D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: asystematic review and metanalysis.

Authors:  Flavio Giuseppe Biccirè; Alessio Farcomeni; Carlo Gaudio; Pasquale Pignatelli; Gaetano Tanzilli; Daniele Pastori
Journal:  Thromb J       Date:  2021-12-18

9.  Prognostic Value of Age-Adjusted D-Dimer Cutoff Thresholds in Patients with Acute Coronary Syndrome Treated by Percutaneous Coronary Intervention.

Authors:  Runzhen Chen; Chen Liu; Peng Zhou; Jiannan Li; Jinying Zhou; Ruoqi Song; Weida Liu; Yi Chen; Li Song; Hanjun Zhao; Hongbing Yan
Journal:  Clin Interv Aging       Date:  2022-02-09       Impact factor: 4.458

10.  Dynamic relationship between D-dimer and COVID-19 severity.

Authors:  Yong Li; Kun Zhao; Hongcheng Wei; Wensen Chen; Wei Wang; Ling Jia; Qiongfang Liu; Jinpeng Zhang; Tao Shan; Zhihang Peng; Yun Liu; Xiaoxiang Yan
Journal:  Br J Haematol       Date:  2020-06-09       Impact factor: 8.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.